Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failure-Reference-Cited by-同舟云学术

Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failure

Published:2003-03 Issue:3 Volume:31 Page:718-728
ISSN:0090-3493
Container-title:Critical Care Medicine
language:en
Short-container-title:Critical Care Medicine

Author:

Abraham Edward,Naum Chris,Bandi Venkata,Gervich Daniel,Lowry Stephen F.,Wunderink Richard,Schein Roland M.,Macias William,Skerjanec Simona,Dmitrienko Alex,Farid Nagy,Forgue S. Thomas,Jiang Frank

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

Reference37 articles.

1. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care

2. A Controlled Clinical Trial of High-Dose Methylprednisolone in the Treatment of Severe Sepsis and Septic Shock

3. Sepsis syndrome

4. Treatment of Gram-Negative Bacteremia and Septic Shock with HA-1A Human Monoclonal Antibody against Endotoxin

5. Management of Septic Shock: Present and Future

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Temporal associations of plasma levels of the secreted phospholipase A₂ family and mortality in severe COVID‐19;European Journal of Immunology;2024-04-23

2. Interactions of small molecule inhibitors with secreted phospholipase A₂: A review of the structural data;Chemical Biology & Drug Design;2024-01-29

3. Goniothalamin prevents lipopolysaccharide‐induced acute lung injury and inflammation via TLR‐4/NF‐κB signaling pathway;Journal of Biochemical and Molecular Toxicology;2023-07-21

4. Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry;Pharmaceuticals;2023-07-12

5. Structural basis of the myotoxic inhibition of the Bothrops pirajai PrTX-I by the synthetic varespladib;Biochimie;2023-04